Clinical Trial Update: Selective Internal Radiation Therapy and 188Re-SSS Lipiodol Treatment for Liver Cancer (Lip-Re2) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating selective internal radiation therapy with 188Re-SSS Lipiodol for unresectable hepatocellular carcinoma. The Lip-Re2 study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Rhenium-188 SSS Lipiodol (Rhenium-188 labeled Lipiodol)
• Selective Internal Radiation Therapy

Snippet

Sponsor: Center Eugene Marquis | Conditions: Hepatocellular Carcinoma Non-resectable | Phase 2 | Status: SUSPENDED